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Objective: To study the trends in mortality over 15 years in hospitalized cancer patients with bloodstream infection. 
Methods: The yearly incidence rates and risk of death, by type of microorganism, were calculated for 4268 cancer 
patients hospitalized between 1975 and 1989 in a French cancer referral center. The relative risk of death (RR) associated 
with each type of microorganism was estimated using the proportional hazards model, taking into account age, hospital 
ward, underlying disease, geographical origin and year of the first positive blood culture. 
Results: The incidence of these infections was five-fold higher in 1989 than in 1975. The largest increases were for 
coagulase-negative staphylococci (CNS), yeasts and Staphylococcus aureus. For the 3756 patients who had a single- 
microorganism bloodstream infection, the risk of death compared with that of patients with CNS infection was 
significantly increased in those with Pseudomonadaceae (RR = 5.0), yeasts (RR = 3.4). Enterobacteriaceae (RR = 3.2), 
S. aureus (RR = 2.8) and streptococci (RR = 2.1). The risk of death was not significantly different between patients with 
a single or several positive blood cultures nor between those with nosocomial or non-nosocomial infections. When the 
study period was divided in  two time periods (1975 to  1982 vs 1983 to 1989), a significant variation (p = 0.001) in risk of 
death associated with the different microorganisms was observed. Most risks were lower from 1983 to 1986 than before 
1982. This decrease reached 60% for both S. aureus and Pseudomonadaceae. 
Conclusions: These data support of continuing use of aggressive empirical antimicrobial therapy for cancer patients 
with fever. 
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Bacterial and fungal bloodstream infections are a 
frequent cause of morbidity and mortality in 
hospitalized patients with cancer [l]. Cancer is an 
independent risk factor for mortality in patients with 
bacteremia [2]. Several changes, which may have 
an effect on the outcome of these infections, have 
taken place over the last two decades. Some of these 
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changes, such as the increased resistance of bacteria to 
antimicrobial agents [3] combined with the increased 
aggressivity of anticancer chemotherapy regimens, may 
have worsened the prognosis. Conversely, the use of 
new antimicrobial agents and the more frequent use of 
modern intensive care facilities for cancer patients [4] 
may have reduced the severity of the disease. 
The present study was carried out to assess, over a 
15-year period, the overall effect of these changes on 
the evolution of the morbidity and mortality associated 
with bacterial and fungal bloodstream infections in 
patients hospitalized a t  the Institut Gustave-Roussy 
(IGR), a large 420-bed tertiary care and cancer referral 
center in a suburb south of Paris. 
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The study included all patients who had at least one 
positive blood culture between 1 January 1975 and 31 
December 1989 while hospitalized at  IGR (medicine: 
38.7%; surgery: 47.3%; pediatrics: 9.8%; intensive care: 
4.0%). During this period, the mean duration of 
hospital stay per patient decreased from 14.6 k 15.8 
days in 1978 to 7.6 ? 9.5 days in 1989. By contrast, the 
number of hospital stays increased from 12,993 in 1978 
to 23,013 in 1989. 
Methodology 
Throughout the study period, a set of three blood 
cultures was routinely drawn from all hospitalized 
patients with fever above 38"C, and additional blood 
cultures were drawn at least daily as long as the fever 
persisted. 
Each 10- to 15-mL blood sample was inoculated 
into two 100-mL culture bottles except in the case of 
children, for whom the sample volume was reduced 
according to their weight. From 1975 to 1 June 1982, 
the bottles were purchased from BioMkrieux (Marcy- 
l'Etoile, France) and contained either brain-heart 
infusion broth (aseptically ventilated on arrival in the 
laboratory) or thioglycolate broth for aerobic and 
anaerobic growth, respectively. Thereafter, the bottles 
were purchased from Koche Diagnostic (Paris, France) 
and contained either brain-heart infusion broth 
[ventilated and adapted to a three-agar (including 
Sabouraud) slide system on arrival at the laboratory] or 
Schaedler broth for aerobic and anaerobic growth, 
respectively. All bottles were incubated at 37°C for 7 
days, checked daily for turbidity or growth on the agar 
slides, and their contents subcultured. The bacteria and 
fungi present in the positive samples were identified 
using the API technique, according to the recorn- 
mendations of the manufacturer (API, La Balme-les- 
Grottes, France). During the period of study, the 
number of blood cultures performed per hospital-day 
increased from 0.02 in 1975 to 0.13 in 1989. 
Data collection 
The eligible patients were identified through the logs 
of the IGR's central microbiology laboratory wherein 
the date of each positive blood culture and name of 
each microorganism identified are recorded. An 
episode of bloodstream infection was defined as the 
occurrence of at least one positive blood culture in a 
given patient. This definition was used for all types of 
bloodstream infection, including those caused by 
coagulase-negative staphylococci (CNS) strains as, in 
hospitalized patients, a single blood culture positive for 
CNS has been found to be associated with an increased 
severity of the prognosis in comparison to patients with 
no CNS-positive cultures [5,6]. 
The characteristics of patients were obtained from 
the main-frame computer and, when necessary, from 
the individual microbiology and/or clinical records. 
The total number of days of hospitalization in each 
ward was also obtained from the main-frame computer. 
The original record of the microbiology data sets 
included 5060 episodes of bloodstream infections 
involving 4286 patients. However, nine staff-member 
patients were excluded because no permission could be 
obtained to see their medical records as were a further 
nine patients who could not be identified because of 
erroneous data reported in the laboratory logs. Thus, 
the mortality study included 5041 episodes in 4268 
patients. 
Two episodes were considered to be separate when 
different microorganisms were isolated after a period of 
at  least 7 days, during which repeated blood cultures 
were negative. Different microorganisms were con- 
sidered part of the same episode when they were 
isolated from blood samples drawn within 7 days. 
Nosocomial infections were those in which the first 
positive blood culture was drawn more than 3 days after 
admittance. 
Description of the study population 
The median age at the time of the firrt positive blood 
culture was 48 (range 6 months to 88) years, and 
the ma1e:female ratio in the population waT 1:3. The 
characteristics of the patients included in the study are 
given in Table 1 and the characteristics of the blood- 
stream infections in Table 2. Most of the patients 
had only one episode of bloodstream infection and a 
single microorganism was usually isolated during each 
episode. About half the patients had one positive 
blood culture per episode. Gram-positive bacteria were 
isolated from more than two-thirds of the episodes 
and most of these were CNS strains. Gram-negative 
bacteria were isolated from one-third of the episodes 
only, and most of these belonged to the family 
Enterobacteriaceae. Anaerobes and yeasts were much 
less frequently isolated. 
Statistical methods 
The rates of incidence of bloodstream infections per 
year were obtained by taking the number of episodes 
occurring each year in the patients included in the 
study as numerators, and the total number of days of 
hospitalization of all patients hospitalized each year in 
the IGK as denominators. 
The risk of death was only analyzed for the 3756 
patients who had a bloodstream infection due to a 
single microorganism and only for the first episode. 
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Table 1 Characteristics of 4268 patients with at least one 
positive blood culture in the course of hospitalization at the 
Institut Gustave-Roussy during the years 1975 to 1989 
Characteristics n % 
Age (years) at first bloodstream infection 
0-19 867 20 
20-39 750 18 
40-59 1571 37 
60-89 1080 25 
Male 2431 57 
Female 1837 43 
Medical" 3608 85 
Gender 
Type of hospital ward 
Surgical 660 15 
Underlying disease 
Epitheliomas 
Upper respiratory tract 802 19 
Breast and female genital organs 703 17 
Other sites 352 8 
Leukemia 481 11 
Other sites and histological types 530 13 
a = including pediatric [n  = 563 (13%)] and intensive care units 
[n = 927 (22%)]. 
Digestive tract 395 9 
Lymphomas 689 16 
Sarcomas (bone or soft tissue) 316 7 
This risk was estimated for a period of 7 days from the 
date of the first positive blood culture using the Cox 
proportional hazards model [7]. CNS bloodstream 
infections were chosen as the reference category with 
five factors considered to be potential confounders: age 
(0 to 19, 20 to 39, 40 to 59, and 60 years or more); 
type of ward (medical us surgical); eight categories of 
disease defined by both anatomical site and histological 
type; geographical origin (France us other countries); 
and year of the first positive blood culture. 
To study the ewlution of the risk of death 
throughout the 15 years under consideration (1 975 to 
1989), this period was divided into two periods of 
similar duration (8 and 7 years, respectively): 1975 to 
1982: and 1983 to 1989. 
Trends in the incidence of bloodstream infections 
The incidence of bloodstream infections increased five- 
fold between 1975 and 1989, ranging from 0.81 to 3.98 
episodes per 1000 hospital-days. There was a marked 
increase in incidence between 1983 and 1986, followed 
by a plateau beginning in 1987. This was mainly 
observed in patients hospitalized in the medical wards 
during the study period (from 0.71 to 3.40 per 1000 
hospital-days), and was less marked in the surgical 
wards. 
Table 2 Characteristics of 5041 episodes of bloodstream 
infections in 4268 eligible patients hospitalized at the 
Institut Gustave-Roussy between 1975 and 1989 
Characteristic Summarized data Further data 
(4 (%) (4 ?A) 
Episodes (n) per patient 
1 
2 
3+ 
1 
2 
3+ 
per episode 
1 
2+ 
Gram-positive 
Microorganisms (n) per episode 
Positive blood cultures (n) 
Types of microorganism" 
Staphylococcus anreus 
CNS 
Streptococci 
Enterococcus species 
Miscellaneous 
Enterobacteriaceae 
Pseudomonadaceae 
Other non-fermenting 
Other 
Gram-negative 
Anaerobe 
Yeast 
3657 
485 
126 
4122 
708 
21 1 
2433 
2608 
3655 
1543 
288 
128 
86 
11 
3 
82 
14 
4 
48 
52 
72 
31 
6 
3 
546 
2327 
832 
165 
32 1 
1208 
339 
69 
17 
11 
46 
17 
4 
6 
24 
7 
1 
< 1  
a = percentages are computed from the total number of episodes: 
the percentage total is > 100 because some patients had episodes 
caused by more than one microorganism. 
CNS = coagulase-negative staphylococci. 
The trends in the incidence of episodes caused by 
the eight main microbial genera are shown in Figure 1. 
The greatest increases were seen for episodes caused by 
CNS strains (from 0.06 to 2.48 per 1000 hospital-days), 
yeasts (from less than 0.001 to 0.1 per 1000 hospital- 
days) and Staphylococcus auieus (from 0.005 to 0.04 per 
1000 hospital-days). There was also a rise, albeit a lesser 
increase, in the incidence of episodes caused by 
members of the family Enterobacteriaceae (from 0.35 
to 0.68 per 1000 hospital-days), Pseudomonadaceae 
(from 0.06 to 0.23 per 1000 hospital-days), streptococci 
(from 0.07 to 0.24 per 1000 hospital-days), enterococci 
(from 0.02 to 0.14 per 1000 hospital-days), and 
anaerobes (from 0.04 to 0.22 per 1000 hospital-days). 
Risk of death according to six potential prognostic factors 
As expected, the risk of death increased with age (Table 
3) and decreased significantly for patients originating 
from a country other than France. Indeed, when 
foreign patients are critically ill, they often return to 
their native countries as an emergency. Although death 
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Figure 1 Trends in the incidence of episodes of 
bloodstream infections caused by eight main microbial 
genera in patients hospitalized at the Institut Gustave- 
Roussy between 1975 and 1989. CNS = coagulase- 
negative staphylococci. 
was likely to have occurred quickly (before day 7) for 
many of these patients, no definite information was 
available for analysis. Thus, as this factor might intro- 
duce some bias into the analysis, this was considered to 
be a potential confounder. 
The risk of death was lower for patients hospital- 
ized in surgical wards than for those in medical wards, 
which included intensive care units. Differences accord- 
ing to underlying disease were slight, but significant 
(p < 0.001; Table 3). 
The overall risk of death at day 7 after the first 
episode of bloodstream infection caused by a single 
microorganism decreased by a significant 50% during 
the 15-year period under study. By contrast, the risk of 
death was not significantly different whether the 
episode was categorized as nosocomial or not. 
Finally, only five factors (age, type of ward, under- 
lying disease, geographical origin and year of first 
postive culture; Table 3) have been taken into account 
in all subsequent analyses. 
Risk of death by type of microorganism 
The risk of death associated with each type of 
microorganism is shown in Table 4. The greatest risk 
Table 3 Risk of death according to five prognostic factors in 3756 patients with bloodstream infections caused by a single 
microorganism 
Factor Patients In ("/I)] RR 95% CI p V d h C  
Age (years) at first bloodstream infection 
0-19 781 (21) 1" 
40-59 1366 (36) 1.7 1.2 to 2.4 < 0.001 
Medicalh 3150 (83) 1" 
Surgical 606 (17) 0.5 0.4 to 0.8 < 0.001 
20-39 641 (17) 1.6 1.1 to 2.4 
60-89 968 (26) 2.1 1.5 to 2.9 
Type of ward 
Underlying disease 
Epitheliomas 
Upper recpiratory tract 727 (19) 1,' 
Breast and female genital organs 622 (17) 0.5 
Other sites 307 (8) 0.7 
Lymphomas 600 (16) 0.7 
Leukemia 413 (11) 0.9 
Sarcoma (bone or soft tissue) 282 (8) 0.5 
Other sites and histological types 466 (12) 0.7 
France 2187 (58) 1" 
Other 1569 (42) 0.8 0.6 to 0.9 = 0.01 
1975 to 1982 1166 (32) 1 2  
1983 to 1989 2.590 (68) 0.5 0.4 to 0.6 < 0 . C ) O I  
N o  1252 (33) 1 
Digestive tract 339 (9) 0.6 
Geographical origin 
Time of the first bloodstream infection 
Nosoconiial infection' 
Ycs 2307 (61) 1.1 0.8 to 1.3 NS 
RR = relative risk of death (utiivariate analysis); CI = confidence intervals; NS 7 not Significant; a = reference category; b = including 
pediatric and intensive care units; c = first positive blood culture drawn > 3 days after admittance (data lacking for 197 patients). 
0.4 to 0.9 
0.4 to 0.8 
0.4 to 1.0 
0.5 to 1.0 
0.7 to 1.3 
0.3 to 0.8 
0.5 to 1.0 
= 0.003 
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was observed in patients with Pseudomonas bloodstream 
infections (RR = 5.0), followed by patients with 
infections caused by yeasts (RR = 3.4), Entero- 
bacteriaceae ( R R  = 3.2), S. aureus (RR = 2.8) and 
Streptococcus species (RR = 2.1). The risks associated 
with anaerobes, miscellaneous gram-negative and gram- 
positive bacteria as well as enterococci were not signi- 
ficantly different from those associated with CNS 
strains. 
Risk of death according to number of positive blood 
cultures 
The risk of death stratified by the microorganism was 
not statistically different whether the patient had single- 
or multiple-organism positive blood cultures (Table 5). 
In addition, the risks shown in Table 4 were not altered 
when the number of positive blood cultures was taken 
into consideration in the analyses. 
Trends in mortality by type of microorganism 
The overall risk of death decreased significantly during 
the 15-year study period according to both the 
univariate analysis (RR = 0.5, p < 0.001; Table 3) and 
the multivariate analysis (z, < 0.001; Table 6). A 
significant decrease in the risk of death was observed in 
patients with Pseudomonadaceae and with S. aureus 
infections, reaching an estimated 60%. This was of 
borderline significance for those with CNS infections. 
Table 4 Risk of death according to type of microorganism in 3756 patients with single-organism (first) bloodstream 
infection (Institut Gustave-Roussy 1975 to 1989) 
Microorganism 
~ ~ 
Patients Death RR 95% CI p value 
[PI (%)I (4 
Gram-positive 
CNS 
Staphylococcus anreus 
Streptocoms species 
Entwococcus species 
Miscellaneous 
Gram-negative 
Enterobacteriaceae 
Pseudomonadaceae 
Other non-fermentative 
Miscellaneous 
Anaerobe 
Yeast 
1591 (42) 
361 (10) 
401 (11) 
91 (2) 
180 (5) 
736 (20) 
137 (4) 
31 (1) 
11 (< 1) 
47 (1) 
170 (5) 
74 
49 
5 
44 
9 
119 
29 
3 
0 
13 
7 
2.8 
2.1 
1 .0 
1.1 
3.2 
5.0 
2.5 
0.0 
1.7 
3.4 
1.9 to 4.0 
1.4 to 3.1 
0.4 to 2.5 
0.6 to 2.2 
2.3 to 4.3 
3.2 to 7.7 
0.8 to 7.9 
No death 
0.9 to 3.0 
1.6 to 7.4 
< 0.001 
< 0.001 
NS 
NS 
< 0.001 
< 0.001 
NS 
NS 
= 0.09 
= 0.002 
~ 
RR = relative risk of death during the 7 days following first positive blood culture, stratified by type of underlying disease and adjusted for 
age, type of hospital ward, and year of onset; C1 = confidence interval; CNS = coagulase-negative staphylococci; NS = p > 0.10. 
a = reference category. 
Table 5 Risk of death according to positive blood cultures in 3756 patients with single-organism (first) episodes of bloodstream infection 
(Institut Gustave-Roussy 1975 to 1989) 
Microorganism 
Posiuve blood culture (n) 
1 2 i  
Total (deaths) Total (deaths) RR 95% CI 
Gram-positive 
CNS 
Staphylococcus sums 
Streptococcus species 
Enterococcus species 
Miscellaneous 
Gram-negative 
Enterobacteriaceae 
Pseudomonadaceae 
Other non-fermentative 
Other 
Anaerobe 
Yeast 
1099 (58) 
126 (17) 
177 (15) 
137 (8) 
54 (4) 
273 (46) 
54 (8)  
23 (2)  
6 (0) 
91 (8)  
19 (4) 
492 (16) 
235 (32) 
224 (29) 
37 (1) 
43 (1) 
463 (73) 
83 (21) 
8 (1) 
5 (0) 
79 (5) 
28 (3) 
0.8 
1 .0 
1.5 
0.4 
0.4 
0.5 to 1.2 
0.6 to 1.8 
0.8 to 2.9 
0.1 to 3.2 
0.1 to 3.2 
0.6 to 1.3 0.9 
1.8 0.8 to 4.0 
0.1 to 16.3 1.5 
0.7 0.2 to 2.2 
0.5 0.1 to 2.2 
No deaths 
RR = relative risk of death for 2 or more positive cultures over 1; univariate analysis with stratification by type of microorganism: the 
differences are not significant; CI = confidence interval; CNS = coagulase-negative staphylococci. 
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The risk of death was virtually constant for patients 
with infections caused by members of the family 
Enterobacteriaceae or by streptococci. The risk of 
death apparently increased markedly for infections 
caused by enterococci and decreased for those caused 
by yeasts. However, the variability in the risk of death 
associated with the various types of niicroorganisms 
during the study tinie period was only of borderline 
significance (p = 0.07; Table 6). 
Table 6 Risk of death after first episode of bactereiiiia caused by a 
single microorganism during the period 1983 to 1989 compared 
with 1975 to 1982 
Calendar time' 
1975 to 1983 to 
Microorganisms 1982 1989 RR 95%C1 
Gram-positive 
CNS 
Sfoplryloioccus aureii: 
Sfrepfptocoiius species 
Eiiterocorcirs species 
Other 
Gram-negative 
Enterobacteriaceae 
Pseudomonadaceae 
Other non-fernientive 
Other 
Anaerobe 
Yeast 
248 
135 
21 1 
27 
26 
406 
38 
4 
0 
63 
8 
1343 0.6 
226 0.4 
190 1.1 
64 2.1 
154 0.2 
330 0.8 
99 0.4 
11 
107 0.6 
39 0 . 5  
27 - 
p <0.001h 
0.4 to 1.1 
0.2 to 0.7 
0.6 to 2.1 
0.2 to 20.0 
0.1 to 0.8 
0.6 to 1.2 
0.2 to 0.8 
0.2 to 1.8 
0.1 to 2.7 
p = 0.07' 
a = tinie of the first positive blood culture; b = test for equality of 
relative risk of death for the two periods; c = test for heterogeneity 
RR = relative risk of death adjusted for age, type of ward, 
gcographical origin, type of microorganism and stratified by 
undei-lying disea3e; CI = confidence interval. 
DISCUSSION 
The incidence of bloodstreani 
dramatically during the 15-year 
cularly in medical wards and for 
infections increased 
study period, parti- 
infections caused by 
CNS strains, yeasts and S. aureus. The highest risk of 
death was observed for patients with infection caused 
by pseudomonads, Enterobacteriaceae, S. aureus and 
yeasts. In addition, the risk of death decreased signi- 
ficantly over the study period for infections caused by 
S. auueus and pseudomonads. However, the variability 
among the different types of microorganisms in the 
evolution of risk of death associated with the time 
period was only of borderline significance. 
Several workers have previously stressed the recent 
increase in the frequency of gram-positive infections, 
particularly those involving CNS strains and strepto- 
cocci, both in the general population [8] and in cancer 
patients [9,10]. The marked increase in CNS infections 
found in the present study was probably related to the 
increasingly frequent use of central venous catheters, as 
reported elsewhere [11,12]. Our results indicate that 
this was not associated with a decrease in the prevalence 
of cases caused by either Enterobacteriaceae or Pseudo- 
nionadaceae, and conform with reports of the general 
hospital population [I 31. 
An increased incidence of nosoconiial yeast 
bloodstream infections over the last 10 years has been 
reported in the United States [I 41. In the present study, 
at least part of the observed increase may have been due 
to change in the blood culture system used. Earlier 
studies have shown that several independent risk factors 
are significantly associated with the occurrence of yeast 
infections in cancer patients [I 5,161. 
The mortality associated in cancer patients with 
blood infections caused by a single bacterial species has 
been frequently studied [17-291, but variations in the 
incidence of such infections over a period of time and 
in the associated mortality have not been reported. 
Furthermore, the trends in nosocomial primary 
bloodstream infections in the US between 1980 and 
1989 have been published, but no emphasis was placed 
on the associated mortality [8]. 
High mortality rates were observed after infection 
in cancer patients by Pseudomonas species [ I  7,28,29], 
members of the family Enterobacteriaceae [ 17,20, 
23,25,26] and yeasts 115,161. Other reports of the 
mortality associated with bloodstreani infections are 
either not recent [22,31] or do not refer specifically to 
cancer patients [30-361 or are limited to a short period 
of observation [37,38]. However, in a 3-year study of 
positive blood cultures, the rates of mortality after 
bacteremic episodes caused by various microorganisrns 
were essentially the same as ours 1371, with the highest 
percentages following infections caused by yeasts, 
Pseudomonas species, S. aureus and menibers of the 
family Enterobacteriaceae 1371. Also, bloodstream 
infection with Pseudomonas aeuuginosa was an inde- 
pendent predictor of death in episodes of nosocomial 
infection [34]. 
In the present study, the high frequency of CNS 
infections observed during recent years can be 
considered to be one of the factors accounting for the 
overall decrease in the risk of death. As already 
described, one feature of the present study was to 
include as case-patients all those with a single positive 
blood culture, including CNS infections. The like- 
lihood that a single CNS-positive blood culture 
represents a true infection is reported to be low [39]. 
It  niay be that the reason why mortality appears to be 
decreasing is that more clinically insignificant con- 
taminants are being counted as infections. However, in 
the present study population, the risk of death was 
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similar whether patients had one or several positive 
blood cultures (Table 5), including CNS infections. 
Anyhow, CNS mortality data was used only as a 
baseline for comparison with other microbial groups. 
The present study results for the risk of death may 
be debatable because only five potential confounders 
were considered. Several other factors, such as neutro- 
penia, might have been included. However, data on 
neutrophil counts at the time of bacteremia were not 
available. In addition, to our knowledge, although 
neutropenia is a major risk factor for infection in cancer 
patients, it has not been reported to be related to the 
bacterial species involved. It is also debatable as to 
whether death was mainly due to the underlying 
disease. Our  hypotheses were that: 1) the mortality 
attributable to cancer was equally distributed among all 
types of infection; and 2) the short duration (7 days) of 
the period of study further decreased this risk, as the 
clinical evolution of cancer is usually much slower than 
that of infection. 
The decrease in the risk of death associated with 
S. uureus between 1975 and 1989 may be accounted for 
by the increasingly systematic early use of vancomycin 
during the 1980s in the IGR [ l l ] ,  as has been 
previously recommended [9,10]. The risk associated 
with members of the family Pseudomonadaceae has 
also decreased, which may be related to changes in the 
use of antibiotics. 
During the 1970s and early 1980s, antimicrobials, 
such as carbenicillin, which have a relatively high 
minimum inhibitory concentration (MIC) against 
pseudomonads [40] were used. These drugs have 
been replaced by agents with lower MICs such as 
piperacillin, ceftazidime and thienamycin [40], which 
became available in France in 1983, 1987 and 1986, 
respectively. Furthermore, most of the first-line eni- 
pirical therapy regimens currently in use include 
compounds such as ceftazidime or piperacillin, which 
are highly active against pseudomonads. This was not 
the case in the early 1980s, when second-generation 
cephalosporins or third-generation cefotaxime were 
commonly used. This may explain the decrease in 
associated mortality, as early initiation of appropriate 
antibiotic therapy has significantly reduced I? ueru- 
ginosu-associated mortality in patients with cancer [ 17). 
The same reasons might also explain why the 
mortality associated with Enterobacteriaceae blood- 
stream infections did not significantly drop, as anti- 
biotics highly active against these bacteria, such as 
the second-generation cephalosporins and cefotaxime 
(since 1981), were already in use as first-line empirical 
therapy throughout the study period. 
The present study results show that the mortality 
associated with bloodstream infections has decreased in 
cancer patients over the 15-year period studied, 
although the incidence of infections caused by most 
microbial species has risen. This decrease may be 
related to the better use of more effective antimicrobial 
agents and constitutes an argument in favor of con- 
tinuation of the strict application of aggressive 
empirical antimicrobial therapy in the management of 
fever in cancer patients [lo]. 
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